A
VIR icon

AlphaQuest’s Vir Biotechnology VIR Stock Holding History

AlphaQuest’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,848
Closed -$23.2K – 2021
2025
Q4 		$23.2K Hold
3,848
– – ﹤0.01% 2079
2025
Q3 		$22K Hold
3,848
– – ﹤0.01% 2084
2025
Q2 		$19.4K Hold
3,848
– – ﹤0.01% 1796
2025
Q1 		$24.9K Sell
3,848
-3,114
-45% -$27.7K ﹤0.01% 1671
2024
Q4 		$51.1K Sell
6,962
-27,493
-80% -$217K 0.01% 1288
2024
Q3 		$258K Buy
34,455
+21,760
+171% +$189K 0.02% 960
2024
Q2 		$113K Buy
12,695
+7,452
+142% +$71.5K 0.02% 901
2024
Q1 		$53.1K Sell
5,243
-20,355
-80% -$207K 0.01% 926
2023
Q4 		$258K Buy
+25,598
New +$234K 0.05% 567

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

AlphaQuest's VIR Position: Q1 2026 in Review

AlphaQuest sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 3,848 shares — an estimated $23.2K sold.

AlphaQuest first reported a position in VIR in Q4 2023 and held it in 9 quarters. The position peaked at $258K in Q3 2024. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • AlphaQuest reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 3,848 Vir Biotechnology shares in Q1 2026, an estimated $23.2K.
  • AlphaQuest first reported a position in Vir Biotechnology in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Vir Biotechnology position peaked at $258K in Q3 2024.
  • 252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.